Form 4: Insuleet Corp Executive Dan Manea Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Dan Manea, SVP and Chief HR Officer of Insulet Corp, reports the acquisition of common stock and stock options.
Summary
- On February 25, 2025, Dan Manea, SVP, Chief HR Officer of Insulet Corp, reported transactions involving the company's securities.
- Manea acquired 1,406 shares of common stock through an annual Restricted Stock Unit (RSU) award.
- These RSUs vest in equal installments over three years and are settled in shares of common stock on a one-for-one basis.
- Manea also acquired 3,559 Non-Qualified Stock Options, which become exercisable in equal installments over four years.
- Following these transactions, Manea beneficially owns 10,703 shares of common stock and 3,559 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reports routine transactions related to executive compensation. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Positives
- The acquisition of shares and stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. This filing is typical for executives receiving stock and option grants as part of their compensation packages.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are common across the medical device industry.
- Companies like Medtronic, Abbott, and Boston Scientific also utilize similar equity-based compensation to align executive interests with shareholder value.
- The vesting schedules and exercise prices are generally in line with industry norms for executive compensation.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders as it aligns executive interests with the company's long-term performance.
Key Dates
| Date | Description |
|---|---|
| 02/25/2025 | Date of the reported transactions: acquisition of common stock and stock options. |
| 02/25/2035 | Expiration date of the Non-Qualified Stock Options. |
| 02/26/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.